Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bromazepam 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Haloperidol 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Pizotifen 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Estropipate 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
pramipexoldihydrochlorid 1,5 mg tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Levonorgestrel 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Estradiol 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Glibenclamide micronised 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Dexamethasone 1.5 mg oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely indapamide 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Podophyllotoxin 1.5 mg/g cutaneous cream |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely ganciclovir 1.5 milligram/1 gram conventional release eye gel (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Alimemazine tartrate 1.5 mg/mL oral solution |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely sennoside B (as sennoside) 1.5 milligram/1 milliliter conventional release oral solution |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Dibrompropamidine isetionate 1.5 mg/g cutaneous cream |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely netilmicin (as netilmicin sulfate) 150 milligram/1.5 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely netilmicin (as netilmicin sulfate) 15 milligram/1.5 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely lispro insulin 150 unit/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely beef insulin (as bovine insulin soluble) 150 unit/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin soluble) 150 unit/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(epr) 15 milligram/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(epr) 5 milligram/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(epr) 10 milligram/1.5 milliliter conventional release solution for injection cartridge |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely phospholipid (as poractant alfa) 120 milligram/1.5 milliliter conventional release suspension for endotracheopulmonary instillation vial |
Has presentation strength denominator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely potassium chloride 750 milligram/500 milliliter and sodium chloride 4.5 gram/500 milliliter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 2.25 gram/500 milliliter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 1.5 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 1.5 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely potassium chloride 1.5 gram/1 liter and sodium chloride 9 gram/1 liter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely potassium chloride 1.5 gram/1 liter and sodium chloride 9 gram/1 liter conventional release solution for infusion bag |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely potassium chloride 1.5 gram/500 milliliter and sodium chloride 4.5 gram/500 milliliter conventional release solution for infusion bag |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
3 |
Potassium chloride 1.5 mg/mL and sodium chloride 9 mg/mL solution for infusion |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Brimonidine tartrate 1.5 mg/mL eye solution |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Unoprostone isopropyl 1.5 mg/mL eye solution |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Propamidine isetionate 1.5 mg/g eye ointment |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely estropipate 1.5 milligram/1 milliliter conventional release vaginal cream (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Meloxicam 1.5 mg/mL oral suspension |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Potassium chloride 1.5 g prolonged-release oral tablet |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
2 |
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |
Product containing precisely dulaglutide 1.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator value |
False |
1.5 |
Inferred relationship |
Some |
1 |